Role and Importance of Tumor Suppressor Genes in Cancer

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".

Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 268

Special Issue Editor


E-Mail Website
Guest Editor
Women's Malignancy Disease Group, Department of Oncology Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231-1000, USA
Interests: breast cancer; obesity; racial disparity; microbiome; signaling; therapeutics
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues, 

Cancer initiation and metastatic progression is a tightly controlled multistep process and multiple factors play a role at every step. Loss of tumor suppressor genes (TSG) by deletion, mutation or functional inactivation by other mechanisms can lead to oncogenesis as TSGs play a pivotal role in cell proliferation, apoptosis, autophagy, migration, invasion and metastatic formation. TSGs can also modulate genomic integrity maintenance, cellular differentiation, DNA damage repair, and signaling pathway regulation. Of note, TSGs can be “gatekeepers” controlling processes involved in cancer initiation, progression and metastasis; or “caretakers” maintaining genomic stability and DNA repair mechanisms; or “landscapers” modulating the tumor microenvironment and potential metastatic niches. Recently, several microRNAs (miRs) and long non-coding RNAs (lncRNAs) have been implicated in their role in tumor suppression coining them as tumor suppressors. Several tumor suppressor genes, miRs and lncRNAs have been shown to play important roles in many cancer types and significant progress is being made to target them for therapeutic purposes. Also, certain environmental cues, infections and toxins have been shown to impact cancer progression by modulating tumor suppressors. Significant progress has been achieved to date; however, further research is still of great importance to better understand the role of tumor suppressor genes in cancer and their therapeutic targeting. For this Special issue of Cells, authors are invited to contribute both original research and review articles.

Prof. Dr. Dipali Sharma
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop